Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 14, 2021

View Archived Issues

Phase III RESCUE study of rAAV2/2-ND4 does not meet primary endpoint

Synairgen initiates phase III study of inhaled interferon beta in hospitalized COVID-19 patients

Phase Ib study of zotiraciclib in recurrent high-grade gliomas meets its prespecified endpoint

NMD Pharma ApS patents new ClC-1 blockers

ChemoCentryx presents PD-1/PD-L1 interaction inhibitors

BioMarin Pharmaceutical identifies HAO1 inhibitors

Fochon Pharmaceuticals synthesizes new URAT1 inhibitors

DNA base composition determines oncogene function

Eisai presents new EphA4-targeting antibodies for AD

Arcutis initiates pivotal phase III studies of roflumilast cream in patients with atopic dermatitis

'Unconventional' gamma-delta T cells recognize malaria-infected RBCs

Interim analysis data from phase IIb study of iDose TR sustained-release travoprost implant

OLT-1177 rescues cognitive impairment in a mouse model of AD

Urinary neopterin is a new biomarker of ALS

Alexion pauses enrollment in phase III study of Ultomiris for severe COVID-19

AAV9-cTuberin extends survival and reduces brain pathology in vivo

Interim data on PD-L1 t-haNK in advanced metastatic pancreatic cancer show improved survival rates

Tislelizumab approved in China for first-line advanced squamous NSCLC

Phase II trial of dexpramipexole in moderate to severe eosinophilic asthma meets primary endpoint

New homozygous deletion in UCHL1 gene tied to Behr syndrome

Daiichi reports phase I/II data on DS-5141 for Duchenne muscular dystrophy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...